| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.087 | 0.03 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.03 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.091 | 0.03 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.13 | 0.04 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.04 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.04 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.04 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.084 | 0.04 |